Skip to main content

Advertisement

Erratum to: Clusterin confers gemcitabine resistance in pancreatic cancer

Article metrics

  • 1474 Accesses

The original article was published in World Journal of Surgical Oncology 2011 9:59

Correction

After the publication of this work [1], we noticed that we had incorrectly used the term ‘OGX-011’. All instances of OGX-011 in the manuscript should be changed to ‘ASO-CLU’.

We apologise to the readers and OncoGenex Technologies for this oversight and any negative effects that may have resulted from it.

References

  1. 1.

    Chen : Clusterin confers gmcitabine resistance in pancreatic cancer. World J Surg Oncol. 2011, 9: 59-10.1186/1477-7819-9-59.

Download references

Author information

Correspondence to Bomin Yan.

Additional information

The online version of the original article can be found at 10.1186/1477-7819-9-59

Qingfeng Chen, Zhengkun Wang, Kejun Zhang contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chen, Q., Wang, Z., Zhang, K. et al. Erratum to: Clusterin confers gemcitabine resistance in pancreatic cancer. World J Surg Onc 11, 149 (2013) doi:10.1186/1477-7819-11-149

Download citation